WebJul 12, 2024 · FTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector On June 7, 2024, the Federal Trade Commission (FTC) unanimously voted to initiate a study into how business practices employed by some pharmacy benefit managers (PBMs) may impact prescription drug pricing and patient access to drugs. [1] WebJul 25, 2024 · This is a repost. You can read the originally published article here.. Senators Maria Cantwell (D-Wash.) and Chuck Grassley (R-Iowa) recently introduced legislation that aims to shed light on the pharmacy benefit manager (PBM) market. The new proposal would prohibit a PBM from engaging in commercial practices known as spread pricing and …
PBM Transparency Act Saves $740 Million: CBO
WebMar 28, 2024 · Senator Chuck Grassley (R-IA) is urging the Federal Trade Commission (FTC) to move forward with the plan to study the business practices of Pharmacy Benefit Managers (PBMs) after the commission came to a deadlocked vote in February. ... Highlighting bipartisan support for a deeper dive into PBM practices, the letter from … WebApr 6, 2024 · The first PBM was founded in 1968. ... the Federal Trade Commission (FTC) unanimously voted to investigate how PBMs operate. A group of House Republican Congressman has asked the US Government Accountability Office to investigate PBMs, and Senators Maria Cantwell (D-WA) and Charles Grassley (R-IA) have introduced … distance from langley to penticton
County of Fairfax, Virginia
Web23 hours ago · The Pharmacy Benefit Manager (PBM) Transparency Act of 2024, a bipartisan effort led by Sens. Maria Cantwell (D–Wash.) and Chuck Grassley (R–Iowa) aims to crack down on middlemen in the ... WebJun 8, 2024 · The FTC action comes less than a month after Senators Chuck Grassley (R-IA) and Maria Cantwell (D-WA) introduced the Pharmacy Benefit Manager Transparency Act of 2024.This legislation seeks to provide greater disclosure of opaque PBM business practices so that the public better understands the anticompetitive impact of PBM … WebFeb 16, 2024 · Grassley tried to assuage Cruz's concerns by saying the measure is a "very narrow approach to this PBM problem through FTC." PBM's defense: PCMA CEO JC Scott said in a statement that the bill considered Thursday "does absolutely nothing to lower prescription drug costs" and would put at risk the savings that PBMs produce. Go deeper distance from la pine to klamath falls